|
|
|
|
|||||
|
|
|
 | |||||||||||||||||||||||||||||
| Group: | Order: | Settings | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| No. | Name | Market Cap. | P/E | Forward P/E | PEG | P/S | P/B | P/Cash | P/Free Cash Flow |
| Dividend Yield | EPS growth past 5 years | EPS growth next 5 years | Sales growth past 5 years | Float Short | Performance (Week) | Performance (Month) | Performance (Quarter) | Performance (Half Year) | Performance (Year) |
| Performance (Year To Date) | Analyst Recom. | Average Volume | Relative Volume | Change | Volume | Number of Stocks |
| Overview | Valuation | Performance | Custom | Bar Chart | Spectrum | Charts |
| No. | Name | Market Cap | PEG | P/S | P/B | Dividend | Float Short | Recom | Avg Volume | Change | Volume | Stocks |
| 1 | Consumer Cyclical | 6068.58B | 1.32 | 1.45 | 3.13 | 0.92% | 4.68% | 2.14 | 1.66B | 2.05% | 1.87B | 577 |
| 2 | Real Estate | 1546.11B | 2.80 | 4.41 | 2.27 | 3.67% | 4.02% | 2.20 | 318.97M | 2.01% | 403.63M | 270 |
| 3 | Financial | 9324.69B | 1.79 | 2.56 | 1.59 | 2.22% | 1.05% | 2.24 | 865.57M | 1.31% | 1.02B | 1120 |
| 4 | Communication Services | 5602.85B | 1.71 | 2.28 | 2.43 | 0.98% | 2.53% | 1.98 | 788.37M | 1.38% | 962.73M | 289 |
| 5 | Technology | 11532.69B | 2.10 | 3.91 | 6.15 | 1.04% | 2.67% | 2.07 | 1.42B | 1.57% | 1.84B | 789 |
| 6 | Basic Materials | 2134.88B | 2.16 | 1.44 | 2.13 | 3.41% | 2.23% | 2.23 | 411.41M | 1.67% | 381.48M | 256 |
| 7 | Industrials | 4818.57B | 1.73 | 1.74 | 3.83 | 1.61% | 3.32% | 2.32 | 530.15M | 1.85% | 600.75M | 652 |
| 8 | Consumer Defensive | 3696.60B | 3.41 | 1.23 | 4.34 | 2.56% | 1.88% | 2.31 | 310.90M | 1.34% | 355.67M | 248 |
| 9 | Healthcare | 7532.97B | 2.80 | 2.00 | 4.19 | 1.57% | 3.67% | 2.12 | 1.20B | 1.19% | 1.39B | 1304 |
| 10 | Energy | 3717.59B | 0.45 | 0.82 | 1.67 | 6.67% | 2.62% | 2.22 | 555.17M | 1.07% | 534.88M | 268 |
| 11 | Utilities | 1476.06B | 2.76 | 1.78 | 1.04 | 3.45% | 1.57% | 2.36 | 151.90M | 0.89% | 231.67M | 114 |
| export |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite